Stonepine Capital Management, LLC 13D and 13G filings for CNS Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 5:10 pm Purchase | 2026-03-31 | 13G | CNS PHARMACEUTICALS INC PA CNSP | Stonepine Capital Management, LLC | 159,790 9.900% | 110,963 (+227.26%) | Filing |
| 2026-02-13 5:02 pm Purchase | 2025-12-31 | 13G | CNS PHARMACEUTICALS INC PA CNSP | Stonepine Capital Management, LLC | 48,827 7.900% | 16,607 (+51.54%) | Filing |
| 2025-11-04 12:19 pm Purchase | 2025-10-29 | 13G | CNS PHARMACEUTICALS INC PA CNSP | Stonepine Capital Management, LLC | 32,220 5.600% | 32,220 (New Position) | Filing |